Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Dec 1;105(12):e282.
doi: 10.1097/TP.0000000000003942.

Preemptive Antibody Therapy for Vaccine Breakthrough SARS-CoV-2 Infection in Immunocompromised Patients

Affiliations
Comment

Preemptive Antibody Therapy for Vaccine Breakthrough SARS-CoV-2 Infection in Immunocompromised Patients

Concetta Catalano et al. Transplantation. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no funding and conflicts of interest.

Comment on

  • Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients.
    Qin CX, Moore LW, Anjan S, Rahamimov R, Sifri CD, Ali NM, Morales MK, Tsapepas DS, Basic-Jukic N, Miller RA, van Duin D, Santella RN, Wadei HM, Shah PD, Gage N, Malinis M, Aslam S, Todesco E, Werbel WA, Avery RK, Segev DL. Qin CX, et al. Transplantation. 2021 Nov 1;105(11):e265-e266. doi: 10.1097/TP.0000000000003907. Transplantation. 2021. PMID: 34310531 Free PMC article. No abstract available.

References

    1. Qin CX, Moore LW, Anjan S, et al. Risk of breakthrough SARS-CoV-2 infections in adult transplant recipients. Transplantation. 2021;105:e265–e266. - PMC - PubMed
    1. Kamar N, Abravanel F, Marion O, et al. Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients. N Engl J Med. 2021;385:661–662. - PMC - PubMed
    1. Hall VG, Ferreira VH, Ku T, et al. Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients N Engl Med. 2021;385:1244–1246. - PMC - PubMed
    1. Ollila TA, Lu S, Masel R, et al. Antibody response to COVID-19 in adults with hematologic malignant disease [published online ahead of print August 11, 2021]. JAMA. 2021. doi:10.1001/jamaoncol.2021.4381 - PMC - PubMed
    1. Weinreich DM, Sivapalasingam S, Norton T, et al. ; Trial Investigators. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N Engl J Med. 2021;384:238–251. - PMC - PubMed